During the past decade, Universitätsklinikum "Carl Gustav Carus"; Klinik und Poliklinik für Dermatologie conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 6 clinical trials were completed, i.e. on average, 85.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 6 clinical trials were completed. i.e. 600% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Universitätsklinikum "Carl Gustav Carus"; Klinik und Poliklinik für Dermatologie" #1 sponsor was "Hoffmann-La Roche" with 4 trials, followed by "LEO Pharma" with 2 trials sponsored, "ViiV Healthcare" with 2 trials sponsored, "Aristea Therapeutics, Inc." with 1 trials sponsored and "Dynavax Technologies Corporation" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Universitätsklinikum "Carl Gustav Carus"; Klinik und Poliklinik für Dermatologie" #1 collaborator was "Merck Sharp & Dohme LLC" with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Universitätsklinikum "Carl Gustav Carus"; Klinik und Poliklinik für Dermatologie" are "Metastatic Melanoma" (2 trials), "Acne Vulgaris" (1 trials), "Advanced BRAFV600 Wild-type Melanoma" (1 trials), "Atopic Dermatitis" (1 trials) and "Basal Cell Carcinoma" (1 trials). Many other conditions were trialed in "Universitätsklinikum "Carl Gustav Carus"; Klinik und Poliklinik für Dermatologie" in a lesser frequency.

Most popular intervention types in "Universitätsklinikum "Carl Gustav Carus"; Klinik und Poliklinik für Dermatologie" are "Drug" (10 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (2 trials), "Cobimetinib" (2 trials), "Pembrolizumab" (2 trials), "Placebo" (2 trials) and "Acnatac® Gel left face" (1 trials). Other intervention names were less common.

The vast majority of trials in "Universitätsklinikum "Carl Gustav Carus"; Klinik und Poliklinik für Dermatologie" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Universitätsklinikum "Carl Gustav Carus"; Klinik und Poliklinik für Dermatologie". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Universitätsklinikum "Carl Gustav Carus"; Klinik und Poliklinik für Dermatologie, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Universitätsklinikum "Carl Gustav Carus"; Klinik und Poliklinik für Dermatologie, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".